ArticleChemistry, an Asian journal2026
Preparation and Characterization of Zein/Salecan Nanocomposite Particles for Enhanced Stability and Bioactivity of Lipophilic Retinoids.
Article in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Retinoids are lipophilic compounds with high biological activity but poor stability and water solubility. Herein, novel zein/salecan (Zein/Sal) nanocomposite particles were fabricated via antisolvent precipitation with polysaccharide coating and used as carriers for hydroxypinacolone retinoate (HPR). The mass ratio of zein to Sal significantly affected particle properties, with a mass ratio of 2:1 yielding a homogeneous spherical morphology and high encapsulation efficiency, while HPR was integrated in an amorphous state. The integration of zein with HPR was due to hydrogen bonding and hydrophobic interactions. The resulting HPR-loaded Zein/Sal nanocomposite particles exhibited good colloidal stability over a wide pH range, under high ionic strength conditions, and during long-term storage. Encapsulation also remarkably improved HPR stability under different temperatures and light irradiation. In vitro assays revealed that the Zein/Sal nanocomposite particles had good biocompatibility, reduced the cytotoxicity of encapsulated HPR, and promoted cellular uptake and migration with the encapsulated HPR. Steady release and improved transdermal delivery of encapsulated HPR were also achieved. These results show that Sal serves as a functional stabilizer, improving both the structural and biological functions of zein nanoparticles, and offering a viable vehicle for the delivery of lipophilic retinoids in food, pharmaceutical, and cosmetic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.